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LETTERS TO THE EDITORS 
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in length and they may have to be edited for publication. 
Re: "Thrombolysis with tissue-plasminogen activator: 
Results with a high-dose transthrombus technique" 
To the Editors: 
We read with interest the article by Ward et al. (J VAse 
SuwG 1994;19:503-8). Their clinical failure rate (52%) and 
major hemorrhage rate (35%) are indeed excessive, and it 
is understandable that they are reevaluating their use of 
thrombolysis with tissue-type plasminogen activator 
(t-VA). 
The Thrombolysis Study Group, a group of 19 
surgeons and 14 radiologists in the United Kingdom, has 
recently built a database of information on peripheral 
thrombolysis. Data are collected prospectively on record 
forms and are entered onto a specially designed computer 
program from which reports on the group's results are 
generated. In the last 12 months 73 patients have been 
treated with an initial high-dose bolus oft-PA. The patients 
treated by the group were similar to those of Ward et al., 
with a 50:50 split in sexes, a mean age of 68 years (range 
19 to 90 years), a mean duration of ischemia of 14 days 
(range 0 to 150 days), and a similar distribution ofischemia 
(17% Fontaine II and 73% Fontaine III). Boluses oft-PA 
ranged from 3 mg to 20 mg for 15 to 30 minutes. These 
boluses were followed by infusions of 0.5 to 3.5 mg/hr for 
up to 4 hours and then, if required, low-dose infusions (0.5 
to I mg/hr). Additional procedures uch as aspiration 
embolectomy, angioplasty, or graft reconstruction were 
required in 62 (85%) patients, 
Seventy-two percent of patients had successful throm- 
bolysis with a mean duration of infusion of 12 hours (range 
0.5 to 27 hours). The limb salvage rate on the thirtieth day 
after treatment was 71% (52 patients). Our amputation 
and death rates were 10% and 19%, respectively. Most 
important he major hemorrhage rate was 11% (eight 
patients, ix at the site of cannulation and two strokes). This 
rate is vastly different from the 35% hemorrhagic compli- 
cation rate in the article by Ward et al. 
Our results in more than three times as many patients 
were reported from 10 centers in the United Kingdom and 
contradict those of the article by Ward et al. Bolus therapy 
with t-PA was significantly faster than low-dose infusion 
and was associated with similar efficacy and complications 
in our patients. The article by Ward et al. is based on a small 
number of patients, and their conclusions should be viewed 
in this light. To establish the role of high-dose bolus t-PA 
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thrombolysis n the management of acute limb ischemia, 
we should await the results of the randomized trial of 
high-dose and low-dose infusions of t-PA that is currently 
in progress by our group. 
B. D. Braithwaite, M_A, FRCS, 
The Thrombolysis Study Group* 
Gloucestershire Royal Hospital 
Great Western Road 
Gloucester GL1 3NN 
United Kingdom 
*Members of the TSG contributing to the results in this letter 
include Dr. A. A1-Kutoubi, Mr. J. Beard, Mr. D.C. Berridge, Dr. 
P. A. Birch, Dr. T. Buckenham, Mr. K. Dawson, Mr. 1. 
Dormandy, Mr. J. J. Earnshaw, Dr. P. A. Gaines, Mr. R. B, 
Galland, Mr. B. P. Heather, Mr. G. Hamilton, Dr. L. Jones, Dr. 
A. Platts, Dr. P. Torrie, Mr. J. Wolfe. 
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Regarding "The incidence of deep venous thrombosis  
in patients undergoing abdominal aortic 
aneurysm resection" 
To the Editors: 
The recent article, "The incidence of deep venous 
thrombosis in patients undergoing abdominal aortic aneu- 
rysm resection," by Olin et al. (J VAse SURG 1993; 18:1037- 
41) addresses the very important issue of patients undergo- 
ing an aortic surgical procedure and whether they have a 
high incidence of deep vein thrombosis. It also brings up 
the very controversial point about whether prophylaxis i
necessary in this group of patients. The authors refer to the 
paucity of data in the literature assessing the incidence of 
deep vein thrombosis (DVT) after an aortic surgical proce- 
dure with iodine 125-labeled fibrinogen leg scanning used 
as the primary method of diagnosis of DVT. 
I would like to suggest that the article written by Byrne 
et al. (Surg Gynecol Obstet 1984;158:419-22) addresses 
this issue quite clearly. We looked at 28 patients who all had 
aortic reconstruction, either aneurysm or aortobifemoral 
bypass. We detected only a 7.1% incidence of DVT in this 
group of patients, and we believcd that an intravenous 
administration of 5000 U heparin during the procedure 
acted as a prophylaxis against he development of DVT. 
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Table  I. L ipoprotein levels in aortic aneurysm and intermittent claudication 
Variable Aortic aneurysm Intermittent claudication Controls 
No.  ' 
Lipoprotein(a) (median; mg/dL) 
Apolipoprotein B (mean ± SD; mg/dL) 
Apolipoprotein AI (mean ± SD; mg/dL) 
Total cholesterol (mean +_ SD; mg/dL) 
Triglyceride (median; mg/dL) 
12 39 88 
51"t 265 16 
1442 24t$ 132 ± 29 129 ± 32 
139 ± 18 149 ± 32 157 ±33 
227 ± 35 234 244 228 ± 38 
246~ 229§ 104 
~Significantly greater than controls, j0 < 0.001. 
tSignificantly greater than intermittent claudication , p < 0.04. 
$Significantly greater than controls, p < 0.01. 
~Significandy greater than controls, p < 0.05. 
Lipoprotein(a) and triglyceride data were analyzed by Kruskal Wallace test; cholesterol, apolipoprotein B,and apolipoprotein At data were 
analyzed by t test. 
The incidence of DVT in the 50 consecutive patients 
undergoing abdominal aortic aneurysm resection who 
were reported in the article by Olin et al. was 18%, which 
is significantly higher than the rate in our article. I think it 
would be important to know whether these patients were 
given heparin during the operation or whether these 
aneurysms were repaired without the benefit of anticoagu- 
lation. We would certainly agree that labeled fibrinogen 
does tend to overestimate he number of clinically impor- 
tant deep ve!n thrombi. The question that still remains is 
whether small thrombi that occur in the tibial vein require 
treatment. I would certainly agree with the authors that a 
randomized prospective study regarding various forms of 
prophylaxis, particularly in terms of whether prophylaxis i
cost-effective, should be done. 
F. Michael Ameli, MB, ChB 
E. K. lones Building 
160 Wellesley St. E. 
Suite 212 
Toronto, Ontario.M4Y 1J3 
Canada 
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Lipoprotein(a) levels in peripheral 
atherosclerotic disease 
To the Editors: 
The association of lipoprotein(a) with ischemic heart 
disease is now well recognized.1 In addition, most prospec- 
tive studies in which lipoprotein(a) levels were assayed 
report that it is also an independent predictor of ischemic 
heart disease risk. 2 In contrast, there have been relatively 
few studies of lipoprotein(a) levels in peripheral athero- 
sclerotic diseases, such as intermittent claudication and 
aortic aneurysm~ Norrgard et al. 3 report that aortic 
aneurysm is associated with high serum levels of lipopro- 
tein(a). Elevated levels.have also been reported in associa- 
tion with intermittent claudication. 4,~ 
To examine further the relationship between peripheral 
atherosclerotic disease and lipoprotein(a), we measured 
serum levels of lipoprotein(a), apolipoproteins B and AI, 
total cholesterol, and triglyceride in patients referred to 
vascular surgeons for evaluation. Lipoprotein(a)was as- 
sayed by ELISA (Terumo, Elkton, Md.); cholesterol and 
triglyceride were assayed by enzymatic olorimetric meth- 
ods, by use of kits from Boeringer-Mannheim (Indianap- 
olis, Ind.) and Sigma Chemical Co. (St. Louis, Mo.), 
respectively; apolip0proteins B and AI were assayed by 
immunoturbidimetry on a Roche Cobas FARA (Belleville, 
N.J.), with use of antisera from INCSTAR (Stillwater, 
Minn.). The study group included 20 women and 31 men, 
aged 68 - 11 years; 39 had intermittent claudication, and 
12 had abdominal aortic aneurysms. These cases were 
compared with 88 age- and sex-matched controls from a 
normative database. Data were analyzed by parametric 
(cholesterol, apolipoproteins B and AI) or nonparametric 
(lipoprotein[a], triglyceride) statistical methods. 
As shown in Table I, lipoprotein(a) and triglyceride 
were significantly increased in both aortic aneurysm and 
intermittent claudication, whereas apolipoprotein B was 
elevated only with aortic aneurysm. Interestingly, both li- 
poprotein(a) and apolipoprotein B were significantly 
higher with aortic aneurysm than with intermittent clandi- 
cation. In addition, apolipoprotein AI levels showed a con- 
sistent rend in the opposite direction. Although this trend 
did not reach statistical significance, perhaps because of the 
small numbe r of subjects in this study, the data are consis- 
tent With the well-known inverse relationshi p between apo- 
lipoprotein AI levels and atherosclerosis. No d'lfferences in
serum cholesterol levels were observed. This is not surpris- 
ing given that the sum of apolipoprotein B and apolipopr0- 
tein AI levels is essentially constant between the three sub- 
groups. 
These data are consistent with previous reports that 
serum lipoprotein(a) levels are elevated in peripheral 
atherosclerotic disease. In addition, we report hat increases 
in serum lipoprotein(a) levels were greater with aortic 
aneurysm than with intermittent claudication. This finding, 
together with the similar result for apolipoprotein B, may 
